Viewing StudyNCT00232661



Ignite Creation Date: 2024-05-05 @ 12:03 PM
Last Modification Date: 2024-10-26 @ 9:19 AM
Study NCT ID: NCT00232661
Status: COMPLETED
Last Update Posted: 2010-02-03
First Post: 2005-09-30

Brief Title: PROACT - Pre-Operative Arimidex Compared To Tamoxifen
Sponsor: AstraZeneca
Organization: AstraZeneca

Organization Data

Organization: AstraZeneca
Class: INDUSTRY
Study ID: 1033IL0039
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: AstraZeneca
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: Francisco Sapunar MD - Arimidex Medical Science Director
Old Organization: AstraZeneca

Collaborators